NeuronesXPAR:NRO -0.44%96 FCF Yield % is 7.58 as of Jun. 29, 2026, which is 50% above its 10-year median of 5.06. GuruFocus rates XPAR:NRO with a GF Score™ of 96/100 and a GF Value™ of €50.24 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 2,866 Software companies, Neurones ranks better than 77.6% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Neurones FCF Yield % Related Terms
Neurones FCF Yield % Historical Data
* Premium members only.
The historical data trend for Neurones's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:NRO vs IBM, ACN, FISV: FCF Yield % Comparison
For the Information Technology Services subindustry, Neurones's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones FCF Yield % vs Software Industry
For the Software industry and Technology sector, Neurones's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Neurones's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurones (XPAR:NRO) has a FCF Yield % of 7.58 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Neurones and its competitors. This is 50% above median its historical median of 5.06. Over the past decade, Neurones' FCF Yield % has ranged from 2.03 to 12.71. According to the industry distribution chart, Neurones ranks #642 out of 2866 companies in the Software industry, placing it in the top 22.4%.
Is Neurones' FCF Yield % too high?
Neurones' current FCF Yield % of 7.58 is 50% above median its 10-year median of 5.06. Over the past 10 years, this metric has ranged from a low of 2.03 to a high of 12.71. The Software industry median FCF Yield % is 0.90. Neurones' value of 7.58 is 742.2% above this industry median. Based on the distribution chart, Neurones ranks #642 out of 2866 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Neurones has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' FCF Yield % compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #642 out of 2866 companies for FCF Yield %. This places Neurones in the top 22% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.90. Neurones' value of 7.58 is 742.2% above this benchmark. Historically, Neurones' own FCF Yield % has ranged from 2.03 to 12.71 over the past decade. While the company's 10-year median is 5.06 vs. the industry median of 0.90, Neurones has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Software company?
The median FCF Yield % among Software companies is 0.90, based on 2,866 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurones's current FCF Yield % of 7.58 is 742.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Neurones and its competitors. For the Software industry, the median FCF Yield % is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurones's current FCF Yield % is 7.58, which is 50% above median its own 10-year median of 5.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.24, compared to a current price of €33.65 — trading 33% below its estimated fair value. The current FCF Yield % is 7.58, which is 50% above median its 10-year median of 5.06 and 742.2% above the Software industry median of 0.90. Neurones' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current FCF Yield % is 7.58 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €33.65 is trading 33% below its estimated GF Value™ of €50.24.
GuruFocus considers Neurones to be Significantly Undervalued.
Key valuation signals for XPAR:NRO:
FCF Yield %: 7.58 (50% above median its 10-year median of 5.06)
GF Value™: €50.24 vs. price of €33.65 (33% below fair value)
Industry Position: 742.2% above the Software median (#642 of 2866)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
96GF Score
Get the complete analysis for XPAR:NRO
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
